Could Isotretinoin Shorten Adult Height? 

• by Kathryn Wighton

• June 4, 2026

FDA Approves Secukinumab for Adolescents With Moderate to Severe Hidradenitis Suppurativa

Secukinumab becomes the only interleukin-17A inhibitor approved for pediatric patients aged 12 years and older with moderate to severe hidradenitis suppurativa.

• by Kathryn Wighton

• March 13, 2026

• 2 min

Lymphocyte transformation test in pediatric drug hypersensitivity: case series report from a tertiary care hospital

• by Olga Rogozina, Susana Martín-López, Fiorela Cinthia Dueñas López, Zoraida del Solar Moreno, Larry Leiva Castrejon, Daniela Aguilar-Concepción, María Jiménez-González, Ana Martínez Feito, Miguel González-Muñoz, Elena Ramírez

• May 15, 2026

Scanning New Horizons (in Digital Pathology)

How biomedical imaging technician Andrew Mullen championed the implementation of digital pathology across a large children's hospital

• April 3, 2026

• 5 min